Legend Biotech Corporation
HealthcareNASDAQ:LEGN · NASDAQ Global Select
-$0.26 today
Vol 1.70M · Avg 2.37M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-2.61%
Period High
$44.32
Period Low
$16.65
Latest
$35.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.33B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.28B
Celcuity Inc.
NASDAQ:CELC
$4.33B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.12B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.80B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.66B
Disc Medicine, Inc.
NASDAQ:IRON
$2.61B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.55B
Zai Lab Limited
NASDAQ:ZLAB
$1.92B
Ascentage Pharma Group International
NASDAQ:AAPG
$414.85M
What is the latest LEGN filing?
The latest filing shown is 6-K dated Jun 2, 2026.
How many recent filings does LEGN have?
Intrinsic Alpha currently shows 20 recent filings for LEGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.